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JNK Jun-N terminal Kinase 
KIF20-A Kinesin-like protein 20A 
L-NAME NG-nitro-L-arginine methyl ester  
LPR Low Pressure Resection 
LPVB Left Portal Vein Branch 
MAP Mean Arterial Pressure 
MAPK13 Mitogen activated protein kinase 13 
MAPK2K1 Mitogen-activated protein kinase 1 
MAPK6 Mitogen-activated protein kinase 6 
MAPK8IP2 Mitogen activated protein kinase –8 interacting protein 2 
  
MCTS1 Malignant T-cell amplified sequence 1 
MDM2 Mouse double minute 2 homolog 
MIB1 Mindbomb, drosophila, homolog of, 1 
MPVT Main Portal Vein Trunk 
MRI Magnetic Resonance Imaging 
mRNA messenger Ribo Nucleic Acid 
NFkappaB Nuclear Factor kappa B 
NME1 Nonmetastatic cells 1, protein expressed in 1 
NME2 Nonmetastatic cells 2, protei expressed in 2 
NO Nitric Oxide 
NOS3 Nitric Oxide Synthase 3 
NOSIP Nitric Oxide Synthase Interacting Protein 
NPM1 Nucleophosmin/Nucleoplasmin family, member 1 
  
OMIM Online Inheritance in Man 
PAI-1 Plasmin Activator Inhibitor-1 
PCR Polymerase Chain Reaction 
PHx Partial Hepatectomy 
PKB/AKT Protein kinase B 
PTMA Prothymosin, alpha 
PVP Portal Venous Pressure 
RAF/MEK1 MAPK/ERK kinase 1 
RhoB RAS homolog gene family, member B 
RHVP Right Hepatic Venous Pressure 
RPVB Right Portal Vein Branch 
RT-PCR Reverse Transcriptase - Polymerase Chain Reaction 
SBDSP Shwachman-Bodian-Diamond Syndrome gene 




SiNoS Significant Nonstationarities 
SiZer Significant Zero crossings for derivatives 
SMA Superior Mesenteric Artery 
SOD1 Superoxide Dismutase 1 
SVR Systemic Vascular Resistance 
TC Truncus Coeliacus 
TGF-alpha Transforming Growth Factor-alpha 
TGF-beta Transforming Growth Factor-beta 
TNF-alpha Tumor Necrosis Factor-alpha 
UBE2C Ubiquitin-conjugating enzyme E2C 
UBE2M Ubiquitin-conjugating enzyme E2M 















































The fact that the liver regenerates after parenchymal loss has been known for a long time as 
reflected in the 8th-century BC Greek myth of Prometheus, a Titan and champion of human 
kind, who stole fire from Zeus and gave it to mortals. For this he was punished by Zeus 
having him bound to a rock in Caucasus where a great eagle ate his liver every day only to 
have it grow back to be eaten the next day and so forth for many years until the hero Heracles 
(Hercules) shot the eagle with an arrow and freed Prometheus from his chains.  
The phenomenon of liver regeneration is most likely a natural developmental 
protective mechanism having prevented liver failure upon mammalian exposure to plant 
toxins, viral hepatitis and possibly parenchymal loss due to liver trauma. In modern times, 
liver regeneration after partial hepatectomy (PHx) has been studied extensively partly because 
the organ affords the possibility to study the molecular and genetic control of the cell cycle as 
it occurs in a synchronised manner after resection, triggered by the changes imposed on the 
organ after parenchymal loss. Furthermore, the need to understand the mechanisms behind 
and find treatment strategies for the acute and chronic failing liver has resulted in a vast 
amount of research on this topic.  
Modern liver surgery has seen the development of split-liver grafting [1] and 
increasingly more aggressive, multimodal treatment of primary and secondary liver 
malignancies, progressively expanding the limits of resectability [2]. Despite continuous 
improvement in surgical technique and perioperative intensive care, patients still occasionally 
suffer from deficient regeneration and functional failure in the so-called small-for-size 
syndrome (SFSS) after liver transplantation if the graft is of marginal size (graft weight/body 
weight ratio, GRWR < 0.8 %) [3] or if the liver remnant is too small after extended 
hepatectomy (< 25 % of remaining, functionally normal liver)[2]. Post-resectional liver 
dysfunction is also a potential problem with the increasing practice of neoadjuvant 
chemotherapy for colorectal metastasis [4]. The vast amount of research to date performed on 
liver regeneration has had relatively little practical consequence for the patient with a failing 
liver except the development of liver support systems such as MARS, bridging the patient to 
transplantation, re-transplantation or as a support during recuperation of the native liver [5] . 
Contemporary liver surgery therefore calls for a better understanding of the mechanisms 
controlling liver regeneration in order to design new treatment strategies to support the 
functionally deficient failing organ and, at the same time, enhance its regenerative capacity be 
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it a small-for-size graft or a failing remnant after extended hepatectomy or a functionally 
































Liver anatomy and physiology 
 
In most mammals, the liver weighs an average of 2.5 % of the total body weight and receives 
approximately 30 % of the cardiac output. It receives dual blood supply – 75 % portal flow 
from the splanchnic organs (stomach, duodenum, small- and large intestine, pancreas and 
spleen) and 25 % arterial flow from the aorta. The hepatic blood drains to three major liver 
veins which join the vena cava inferior draining in turn to the right atrium. The liver is the 
largest internal organ in the body with vital functions in carbohydrate and lipid metabolism 
and protein synthesis. It also has important immunological functions in filtering the portal 
blood via the reticuloendothelial system, removing bacteria and endotoxin translocated from 
the gut to the portal circulation and contributes to the digestive process by its production of 
bile.  The liver is also plays a major role in drug metabolism. The functional unit of the liver, 
the liver lobule, consists of rows of hepatocytes lined on one side by fenestrated sinusoidal 
endothelial cells, and on the other by biliary cells forming bile canaliculi. The blood from the 
hepatic artery and the portal vein are united in the liver sinusoids perfusing dynamic 
fenestrated endothelial lining, draining at last into hepatic venules that coalesce into liver 
veins. The liver accommodates passively increases in blood flow from the portal circulation to 
a large degree [6], although there is some intrinsic flow regulation: - intrahepatic portal 
vascular resistance sites are found in post sinusoidal veins [7,8] and pre-sinusoidal sinusoidal 
flow is regulated by the Hepatic Arterial Buffer Response (HABR) (increased portal flow to 
the liver results in increased washout of adenosine surrounding pre-capillary sphincters, 
resulting in hepatic arteriole constriction. Conversely, reduced portal vein flow results in a 
compensatory increase in the hepatic arterial flow [9]). Portal vein ligation illustrates the 
compliance of the vascular bed in the liver – upon ligation of one half of the liver, the flow to 
the contralateral side increases by a factor of four [10]. This is clearly seen in the expanding, 
distended portal vein tributaries in portal vein angiograms after portal vein embolization [11]. 
Hepatic flow is further under sympathetic regulation from circulating noradrenaline and local 
nerve endings [12] and is influenced by systemic nitric oxide [13,14], endothelin-1 and 
cyclooxygenase-derived prostaglandins [15] and histamine [16].  
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Models of regeneration 
   
Portal flow 
The study of liver regeneration was largely triggered by Eck’s seminal paper on complete 
portocaval shunting (PCS = Eck fistula) in dogs in 1877 [17] which led to the belief that the 
liver was not dependant upon portal blood perfusion. However, this was later contested by 
Hahn in 1893 [18] whose dogs deteriorated with the Eck fistula, showing signs of liver 
atrophy, weight loss and encephalopathy. The changes incurred by PCS were, for many 
ensuing years, thought to be the result of a lack of portal flow through the liver (as 
distinguished from the lack of the hepatotrophic substances transported to the liver in the 
portal blood). This “flow theory” seemed unquestionable after Child’s model of portocaval 
transposition in 1953, where, after a 70 % PHx in dogs, the portal vein and vena cava inferior 
were switched surgically, resulting in the liver remnant regenerating by 50 % despite its 
receiving only systemic blood from the caudal stump of the vena cava inferior [19]. Further 
solid support to this theory came from several canine experiments conducted in the 1950’s 
and early 60’s with portal vein arterialisation (after portocaval shunting) showing that this 
manoeuvre would, not only arrest the changes incurred by the Eck fistula such as “meat 
intoxication”, weight loss of the animals and liver atrophy [20-22], but also allow liver 
regeneration to occur after a 42 % PHx [23].  
 
Portal blood constituents 
With the advent of auxiliary liver grafting in the early 60’s unveiling the phenomenon of graft 
atrophy due to the portal steal effect of the native liver, came the realization that there must be 
certain hepatotrophic substances delivered to the liver in the portal blood only, which the 
organ is dependant upon to regenerate and / or maintain its volume and function [24]. One 
could no longer regard the liver’s homeostasis as a result of mechanical portal flow stimulus. 
Numerous experiments with canine models of split portocaval transposition (one portal 
branch perfused with blood from vena cava inferior and the other portal branch perfused with 
portal blood draining splanchnic organs, with similar flow rates and oxygen tension) in the 
period 1965 to 1978 revealed the importance of hormonal and nutritional influence of portal 
blood on liver regeneration, in particular insulin. After three months of this vascular 
rearrangement in dogs, one observed hypertrophy with glycogen deposition, increased DNA 
synthesis and mitosis on the side receiving splanchnic blood and atrophy on the side receiving 
systemic blood [25-28].  Substituting the blood flow in one of the portal vein branches with 
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arterial flow (and increased oxygen delivery) over three months could not compensate for the 
qualitative loss of the portal blood stimulus [29].  
 Given that the trophic substances seemed to be found in the portal blood, subsequent 
investigations were designed to disclose their origin. Surgical models with separation of the 
portal inflow coming from the upper GI-tract (distal stomach, duodenum, pancreas and 
spleen) from that originating from the small intestine (model of splanchnic flow division), and 
various degrees of splanchnic evisceration confirmed that the major trophic substances 
emanated from the upper GI-tract and consisted of insulin and possibly glucagon [30-36]. 
 With the importance of portal blood constituents for liver maintenance and regeneration 
firmly established, research evolved to screen for other potential hepatotrophic substances in 
the portal blood. Canine models of Eck fistula in the early 90’s, revealed that Insulin and 
partly T3, IGF-II, HSS, TGF-alpha, and HGF inhibited liver atrophy [37]. TGF-beta increased 
the atrophy but this effect was reversed upon concomitant insulin infusion.  
 Despite the numerous surgical models with splanchnic vascular manipulation and liver 
transplantation over a period of approximately 100 years implying the dominant role of 
humoral regulative mechanisms initiating liver regeneration and maintaining liver 
homeostasis, new studies in the late 90’s appeared suggesting that increased sinusoidal flow 
and sinusoidal shear stress after PHx could play a role after all [38,39]. Increased endothelial 
shear stress was shown to trigger NO production [40-42] and later, liver regeneration after 
PHx in rats was shown to be inhibited by the administration of the NO antagonist NG –nitro-
L-arginine methyl ester, and restored by the NO donor 3-morpholinosydnonimine-1 (SIN-1) 
[43,44]. These studies therefore implicated that the increase in sinusoidal flow per gram 
remaining liver parenchyma after PHx initiates liver regeneration through de novo synthesis 
of NO. So the question of whether liver flow per se is detrimental to liver regeneration seems 
unsettled. 
 
The role of liver oxygen status & energy load 
In a canine Eck fistula model in 1952, it was observed that arterialisation of the portal vein 
stump over 4 months prevented liver atrophy [45]. Consequent long term canine experiments 
performed the next ten years in animals with Eck fistula and portal vein stump arterialisation 
showed that this altered hepatic vascularity was compatible with life, although many reported 
the development of vascular damage, and liver fibrosis progressing to cirrhosis [46-50]. In 
1954, one observed superior liver regeneration in dogs after a 42 % PHx model with Eck 
fistula and arterialisation of the portal vein stump (controls regenerated to 80 % of original 
 13
volume versus 103 % in the arterialised group) and hypothesized that the increased oxygen 
delivery contributed to this difference [51]. Later, liver grafts were shown to survive on 
arterial blood only [52] and arterializing of the portal vein stump could reverse the atrophy  
caused by an Eck fistula [53]. Furthermore, recent porcine models of liver PHx with portal 
vein arterialisation have even shown enhanced regeneration compared to pigs with portal 
perfusion of the liver remnant also suggesting beneficial effects of increased oxygen delivery 
[54].  In the clinical setting, portal vein arterialisation has been found useful in counteracting 
the portoprival state of the liver and hepatic encephalopathy in cirrhotic patients with 
portocaval shunting [55,56] and beneficial in humans after extended hepatectomy [57]. 
 Increased energy status in the remnant may explain beneficial effect of arterialisation. 
Rodent models of PHx from the 1970’s and canine models from the 1990’s have shown that 
the capacity of the liver remnant to regenerate after PHx is dependant upon an increased 
supply of energy [58-61] and arterialisation of the liver remnant leads to improved survival in 
rats after extended hepatectomy [62-64].  
 
The liver as a source of growth factors  
The liver itself is also a source of growth factors and cytokines which play a vital role in 
regeneration. In 1952, Glinos and Gey found the serum of partially hepatectomized rats to 
exert a growth-promoting action on fibroblasts in tissue culture [65]. Around the same time, 
other investigators reported an increased number of mitoses in the non-hepatectomized 
partner in parabiotic rats with cross circulation indicating the presence of growth stimulating 
factors in the effluent from the liver remnant [66,67]. This hypothesis was corroborated by 
later by observations of increased liver cell mitosis in intact rodent livers injected with serum 
from hepatectomized counterparts [68,69]. To circumvent the changes in portal 
hemodynamics caused by PHx, canine experiments in the early1960’s with 
autotransplantation of small liver grafts to the jejunal mesentery, followed by randomization 
to 70 % PHx of the native liver or control, revealed that the autografts in the animals with 70 
% PHx did not undergo atrophy, indicating again a growth stimulus from the resected liver to 
the autografts via the systemic circulation [70]. In later canine models of heterotopic 
allografting in the 1960’s, the grafts did not suffer from atrophy when the native liver, 
receiving all the portal blood, was resected, again indicating a growth stimulating effect from 
the liver effluent after PHx [71]. Later, Starzl extracted cytosol from hepatectomized canine 
livers (48 and 72 hours after PHx) injecting it into the portal vein stump of dogs with Eck 
fistula, observing a proliferative response [72]. A year later it was observed that the growth-
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stimulating factor in the cytosol extract from regenerating canine livers (termed Hepatic 
Stimulatory Substance, SS) was organ specific in that it did not stimulate any glomerular 
proliferative activity when injected into the renal artery. Investigating how factors in the 
recipient liver influenced the action of SS, Terblanche injected regenerative liver extract into 
the portal vein perfusing normal canine livers without any response. However, an augmented 
proliferative response was seen upon injecting the extract into the portal vein of resected 
livers 48 and 72 hours after PHx [73]. Further investigations of a possible growth stimulatory 
substance in the liver effluent from partially hepatectomized pigs was performed by van 
Hoorn-Hickman in 1981 by cross circulation with recipient animals or exchange perfusion. 
Increased thymidine kinase activity and mitotic indices in biopsies from portocaval shunted 
(recipient) pigs corroborated Starzl’s previous observations in dogs [74]. Kahn also showed in 
1982 that a stimulatory substance was transferred from a transplanted partially 
hepatectomized liver to the host liver (which had a portocaval shunt), stimulating a 
proliferative response in the latter (as judged by increased thymidine kinase activity and 


















Contemporary research – has it helped? 
The focus of research on liver regeneration after PHx has expanded greatly during the last 
three decades since the pioneering surgical models described above. Focus has turned from 
examining “causative” factors such as portal- and hepatic arterial blood flow and its content 
towards the intrinsic consequences these changes have in the extra cellular matrix, the 
intracellular signal transduction mechanisms and genetic response in the liver during 
regeneration. Studies in various cell culture models, rodent knockout- and knockdown 
models, stem cell transplantation, microarray analysis, the impact of the immune system, 
blood platelets and serotonin, the complement system, cytokines, and the interaction between 
the many different cell types now known to regulate the regenerative process has 
unquestionably added much knowledge to the research on liver regeneration. However, the 
picture has become quite complex and seemingly increasingly intangible when it comes to the 
clinical application of the knowledge gained. This is partly expressed in recent reviews by 
authorities on liver regeneration, summarizing the vast amount of published literature on the 
molecular control of liver regeneration in the past 20-30 years. Concluding her review in 
2004, Rebecca Taub writes, “what remains unclear is how the size of the liver is determined”, 
“how the known molecular pathways necessary for liver regeneration are altered in human 
disease”, and that “greater insight will be required to develop improved pharmacological 
therapeutics and surgical approaches” [76].   In Nelson Fausto’s review from 2006, the author 
concludes that what is needed is a more “rigorous effort to apply the knowledge gained in 
experimental work to solve clinical problems”[77]. And in his recently published Rous-
Whipple Award Lecture (2010) Michalapoulos concludes that “liver failure, essentially a 
failure of regeneration, should be subject to mechanistic analysis based on knowledge already 
gained on regeneration, and perhaps therapeutic interventions may be designed with impact 
on human liver disease” [78].  
How then has research on liver regeneration in the past 133 years benefited the patient 
with liver cirrhosis, acute liver failure or liver metastasis?  The recognition of the importance 
of portal blood to liver homeostasis and regeneration was obviously detrimental to the 
pioneers of liver transplantation as they observed how the auxiliary graft would undergo 
atrophy without portal blood constituent stimulus [79]. The earlier canine and porcine 
experiments of portal vein arterialisation [80-87] also illustrated to the transplantation 
surgeon, that the auxiliary graft could be supplied perfused by PVA as an option to leave the 
hilus of the native liver untouched and in cases of portal vein thrombosis [88-91]. 
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Furthermore, as part of the emerging multimodal three stage treatment of colorectal 
metastases [2], surgeons now often embolize the portal vein before performing large 
resections in order to stimulate liver hyperplasia in the remnant to be, thereby avoiding 
postoperative liver failure, having appreciated  that diverting portal flow away from one side 
to the other resulting in hypertrophy the future remnant (described as the “parenchymal shift” 






































Faced with the prospect of an increasing incidence of primary and secondary liver 
malignancies due to an ageing population and the rising use of multimodal treatment with 
neoadjuvant chemotherapy to downstage colorectal metastasis, contemporary liver surgery 
necessitate a better understanding of the mechanisms controlling liver regeneration in order to 
design new treatment strategies to support the functionally deficient failing organ be it due to 




To illustrate how analysis of real time data in time series (derived from research on liver 
hemodynamics) using novel statistical analysis may complement traditional statistical 
methods as the technique enables the observer to utilize all data points from real time 
sampling and explore the data at multiple time scales. 
 
Paper 2 
To investigate if the pressure and flow differences in the liver remnant after a 62% and a 
75% resection generate different gene activation patterns corroborating the theory of shear 
stress induced initiation of the regenerative response. 
 
Paper 3 
To distinguish the effects two different stimuli potentially initiating liver regeneration 
after partial hepatectomy: - increased sinusoidal flow/shear-stress in the liver remnant vs. 
increased delivery of hepatotrophic factors in the blood perfusing the liver remnant. 
 
Paper 4 
To review the published English literature on large animal research on liver regeneration 














With the advent of increasing computational power and real-time recordings from 
hemodynamic studies, one is increasingly dealing with vast amounts of data in time series 
the analysis of which with traditional methods of statistical analysis is inadequate.  
 
Paper 2 
Increase in the flow per gram remaining liver tissue, as reflected in the increase in portal 




According to the “flow theory” of liver regeneration, it is the increased sinusoidal flow in 
itself, and not the increased delivery of potential hepatotrophic substances in the portal 
blood which is the primary stimulus to liver regeneration. 
 
Paper 4 
Reviewing the published literature on large animal research on liver regeneration will 




















Materials and methods  
 
Animals and instrumentation 
 
Castrate sus scrofa domesticus were used for all experiments which were conducted in 
compliance with the institutional animal care guidelines and the National Institute of Health’s 
Guide for the Care and Use of Laboratory Animals [DHHS Publication No. (NIH) 85-23, 
Revised 1985]. The animals were an average of three months old, weighing on average 32 kg 
(SD 2 kg). All animals were operated upon between 0800 and 1200 hours. Anesthesia was 
induced with intramuscular Ketamine (10 mg/kg) and atropine (0.05 mg/kg) and Fentanyl 
(0.2mg/kg), and maintained with 1.5-2% Isoflurane mixed with 55% oxygen. Analgesia was 
maintained with Fentanyl 0.01 mg/kg. Respiratory rate was adjusted to achieve an end tidal 
CO2 between 3.5 and 6 KPa. Mean alveolar concentration of Isoflurane was maintained at 1.3 
using a Capnomac (Nycomed Jean Mette). Before surgery, all animals received a single i.m. 
shot of antibiotic prophylaxis (Enrofloxacin, 2.5 mg/kg). For hemodynamic monitoring (in all 
acute experiments), a 16G central venous catheter  (CVK, Secalon® T) was placed in the left 
femoral artery for continuous arterial blood pressure recording (MAP). A 7 French 110  
cm angiographic catheter (Cordis®, Johnson&Johnson) was placed in the hepatic vein 
draining segments V and VIII via the right internal jugular vein for right hepatic venous 
pressure monitoring. A paediatric CVK (Arrow® International) was placed in the portal vein 
with the tip approximately 5 cm from the liver hilus for portal pressure monitoring. A 5 
French Swan-Ganz catheter (Edwards Life sciences™) was floated via the right external 
jugular vein to the pulmonary artery for cardiac output (CO) measurements. 
Calibrated transducers  (Transpac 3™, Abbott Critical Care Systems, Chicago, IL, USA) were 
used for real time pressure registration. The transducers were connected to an amplifier 
(Gould, 2800S, Ohio, USA). Pulsatile signals were displayed on a monitor, digitalized and 
stored electronically (Advantech, Industrial Computer). All recordings were logged every 
fourth second. Perivascular ultrasonic flow probes (CardioMed Systems, Medistim A/S, Oslo, 
Norway) were placed around the portal vein (12mm probe). Signals were displayed on a 
monitor and stored electronically (Advantech, Industrial Computer). Blood extraction was 
performed prior to biopsy sampling. Samples were taken from the portal vein, femoral artery 
and hepatic vein. IL-1, IL-6, TNFα, TGF-α, TGF-β, and EGF were analyzed using ELISA 
(Quantikine®, R&D systems, and Searchlight® Pierce Biotechnology, MA, USA) and ASAT, 
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ALAT, GT, pyruvate, glucose, lactate, ALP levels were quantified by calorimetric, UV-
photometric and HPLC analysis (Roche®, PerkinElmer®). 
 
Paper 1 
All calculations in paper 1 are based on hemodynamic recordings from experiments reported 
Figure 1. Illustrates below il
in paper 2 and 3. (Figure 1) 
lustrates the four experimental groups from which the data are 
 







(HR), Right Hepatic Venous Pressure (Vp), Portal Venous Pressure (Pp), and Portal Venou
Flow (Pf). Each set was analyzed with three different statistical methods: 1) Repeated 
Measures ANOVA, 2) Linear Mixed Models and 3) Time series analysis with the Sign
Nonstationarities (SiNoS) method. For analysis with the two first methods, data was extracted 
from the real time data material with exact 10-minute intervals and analyzed using SPSS 13 
for Windows statistical package. P values ≤ 0.05 were considered statistically significant. 
When analyzing with Repeated Measures ANOVA, we studied within-group trends with 
within-subjects effects for time and group*time. Overall group difference was analyzed w
between-subjects effects.  When analyzing with Linear Mixed Models we performed multiple
local ANOVAs for consecutive one-hour time periods starting at t = 0 minutes (0-1hr, 1-2hrs, 
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etc) and t = 30 minutes (30-90’, 90-150’ etc) and for two-hour time periods starting at t = 0 
minutes (0-2hrs, 2-4hrs etc). We defined time as a fixed factor and subject as a random effec
As recommended by Norusis [93], an autoregressive AR1 covariance matrix was used. Time, 
group and group*time interaction were tested.   
 To analyze 
t. 





the Significant Nonstationarities (SiNoS) method. Briefly, in SiNoS, the data is analyzed 
simultaneously for several time horizons by basing the inference on repeated tests along th
time series, comparing the estimated parameters on consecutive segments of the series. The 
lengths of the segments represent the time scales for the analysis and different lengths are 
used to detect changes on different time scales, making it possible to judge which scales th
seem to have the most meaningful interpretation. For a chosen test point, t1, we perform two-
sampled hypothesis tests for the mean (μ), the variance (σ2) and the first lag autocorrelation 
coefficient (ρ), comparing estimated values in the two windows W1 and W2 on each side of 
t1. The total length of the two windows W1 and W2 represents the scale for the analyses. For
each scale the hypothesis testing is repeated along the time series by sliding the two 
consecutive windows to the next chosen test point t2. By applying different window 
potential changes are explored on different time scales. To avoid a large number of false 
detections, we adjust for multiple testing with the method of False Discovery Rate (FDR) 

















Paper 2  
 sus scrofa domesticus were used for all experiments. Three pigs underwent a 62 
h-
   
igure 2. Illustrates the segmental anatomy of the porcine liver and two different grades of 
 
ll hemodynamic recordings were made with sampling points every 4th second for six hours 
es 




the samples were combined pair wise and hybridized to the pig array DIAS_PIG_55K2, 
Six castrate
% liver resection removing segments II, III, IV, V and VIII (low-portal pressure resection, 
LPR) and three underwent a 75 % resection removing in addition segments VI and VII (hig
portal pressure resection, HPR).  
 
 
Normal   62 % PHx      75 % PHx 
 
F
resection (PHx).  
 
A
after completion of liver resections. Biopsies for microarray analysis were taken from the 
remaining segments VI, VII in the LPR series and from segment I in the HPR series and 
placed immediately in RNALater (Ambion®). Sampling time points were 1, 30, 90, minut
and 3, 4 and 6 hours after resection.  
  The microarray experiments w
total-RNA purified from an unrelated animal as the reference allowing comparison of all the 
different samples to each other (the acute phase response due to the operation in itself could in
theory affect gene expression in both groups of liver remnants, however, as the perioperative 
conditions were almost identical, we considered this effect to be equal for the two resection 
groups and chose not to use a sham as the reference). Total-RNA was purified and 
aminoallyl-cDNA (aa-cDNA) was synthesized from 20 µg of total-RNA. The refere
sample was labeled with Alexa 488, each individual sample was labeled with Alexa 594 
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which consists of 26879 PCR products amplified from unique cDNA clones. Following 
hybridization, washing and drying, the slides were scanned and the median intensities we
computed. Statistical analysis was carried out in the R computing environment using the 
Bioconductor package Linear Models for Microarray Analysis (Limma) [95,96]. The log2-
transformed ratios of Alexa-594 to Alexa-488 were normalized within-slide using print tip
loess and analyzed to identify genes being significantly differentially expressed by time 
within treatment as well as between treatments. Time contrasts were formed referring to the
sample taken at time point 1 min. The genes found significantly expressed between at lea
two time points were further analyzed referring to Online Mendelian Inheritance in Man 
(OMIM®, [97]) and Gene Ontology® (GO®)  to group the genes by function. More detailed 
descriptions of the microarray experiments are available at the NCBIs Gene Expression 
Omnibus [98-100] through the GEO series accession number GSE6860.  
The data was analyzed within each resection group (LPR and HPR) in two ways:


















 PHx) we classified all genes into 14 functional groups by molecular function and 
biological process according to the GO® and OMIM®. Secondly, using K-means clustering w
defined 20 clusters in each group and selected from these 8 clusters of special interest on t
basis of their non-uniform profiles for closer analysis with GO® and OMIM®. For direct 
comparison of the two resection groups we investigated the genes which were expressed in 
both groups at each time point, selecting those which had a statistically different expressi
level in the two groups (herein termed “within time point contrasts”). We avoided using fold
change cutoff values because this approach fails to take the uncertainty of variability into 
account (i.e. a gene may exhibit a tenfold change and yet not be significant because of its 
variability), and has the potential of excluding genes of biological importance whose 
expression values are below the cutoff value.  
For RT-PCR validation, sets of two primers and a probe for 8 chosen target ge
1 control gene (18S) were designed using the P
d Biosystems). To avoid genomic DNA contamination the primers were designed to 
span exon boundaries. The probes for the target genes were labelled with either the 
fluorescent reporter VIC or SYBR Green. 5 μg total RNA of each sample was reverse 
transcribed using random hexamer primers and SuperScript II Reverse Transcriptase
(Invitrogen). Real-time quantitative RT-PCR was performed on the ABI Prism 7900HT
sequence detection system (Applied Biosystems) by monitoring the increase in fluores
due to the binding of SYBR green or VIC to double-stranded DNA. The amplification 
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conditions were as follows: 50°C for 2 minutes, 95°C for 10 minutes and 40 cycles each of 
95°C for 15 seconds and 60°C for 1 minute. Each cDNA sample was run as technical 
triplicates. The standard curve method was used to calculate the relative mRNA levels. The 
quantity mean of the triplicate measurements were normalized against the 18S gene an
of the biological replicates were calculated as well, yielding a single value for each time poin
The profiles of these values were compared to the profiles of the microarray data. 
 
Paper 3  
d mean 
t. 
This paper is a combination of an acute- and chronic series of partial portal vein arterialisation 
nd IV. 
cute series:
(Figure 3).  
 




A  After a midline laparotomy and placement of all catheters and flow probes as 
escribed above, we isolated and recorded the flow in the left portal vein branch (LPVB). 
When the activated clotting time (ACT) was above 250 seconds, a 5mm Propaten Gore-Tex™ 
d
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graft was anastomosed end-to-side from the aorta (between truncus coeliacus (TC) and the 
superior mesenteric artery (SMA)) to the LPVB. The LPVB was then ligated proximal to t
bifurcation to prevent backflow to the main portal vein trunk (MPVT). The opening of the 
shunt was regarded as time = 0 and noted. Flow in the shunt was standardized in each 
experiment to 1000 mL/minute by gradual shunt constriction using a ligature and a 
perivascular flow probe. Sham surgery consisted of all the steps above except for the 
establishment of the aortoportal shunt.  
he 
Chronic series:  After a midline laparotomy, a similar shunt was placed from
to the LPVB once the animal had received 5000 IE Heparin i.v. We used an interposed
graft from a donor pig in the chronic ser
 the aorta 
 aorta 




d. The LPVB was ligated proximal to the portal bifurcation to prevent backflow to the 
MPVT. Flow was standardized (by concentric constriction with a ligature) to 1000mL/minute
Upon relaparatomy three weeks later, the shunt was isolated and flow measured. The flo
the MPVT (now supplying the right liver only) was recorded.  
In the acute series, sequential biopsies were taken from the shunted segments II, III 
and IV at time points 1, 5, 10, 30, 60, 90 minutes and 2, 3, 4 and 6 hours after shunt opening 
(t = 0). The sampling time points were the same as in a previous study of liver regeneration 
after PH  
e 
otransferase (ALAT), glutamyl transpeptidase (GT), 
tes using 
102]. 
x [101] using the same microarray platform allowing the direct comparison of gene
expression profiles found in the present experiments with the former. Biopsies were placed 
immediately in RNAlater (Ambion®).  
  Blood extraction was performed before biopsy sampling. Samples were taken from th
portal vein, femoral artery, and hepatic vein draining both sides of the liver. Aspartate 
aminotransferase (ASAT), alanine amin
glucose, bilirubin (Bil) and alkaline phosphatase (ALP) levels were quantified by 
calorimetric, ultraviolet-photometric, and HPLC analysis (Roche, PerkinElmer). 
For cytokine analysis, a multiplex kit was developed including four different 
cytokines; TNF-α, IL-1α, IL-6 and IL-10.  Serum samples was analyzed in duplica
the Luminex 200™ with the Bioplex manager software (BioRad, Hercules, CA) [
 26
In the sham series, liver biopsies were taken from segments II, III and IV and 
was sampled from the same locations at the same time points as in the shunted animals.  
 
blood 
In the chronic series, only peroperative arterial blood gas samples were taken (directly from 
the aorta) to monitor respiratory status.  
 
were fixed in buffered formalin, paraffin 
embedded, a
A literature search was performed in Pubmed with the following terms: liver regeneration, 
nimal, canine, porcine, and pig. Further peer reviewed research papers were obtained from 
e lists of the articles retrieved.  
To evaluate the long-term (3 weeks) effects of arterial hyperperfusion on the liver
parenchyma we took biopsies from both the shunted and the portally perfused sides of the 
liver before and after shunting. Specimens 
nd stained with Hematoxylin-Eosin (HE) to evaluate tissue architecture. To 
evaluate proliferative activity, sections were stained with Ki67 and Phosphohistone H3. The 
proliferative index was estimated by counting the number of Ki67 positive cells relative to the 
number of non-stained hepatocytes per liver lobuli. Connective tissue distribution was studied 
























We found SiNoS analysis more comprehensive when compared to traditional statistical 
analysis in four ways: One, the method allows better signal to noise detection; two, including 
all data points from real time recordings in a statistical analysis permits better detection of 
significant features in the data; three, analysis with multiple scales of resolution facilitates a 
more differentiated observation of the material; and four, the method affords excellent visual 
presentation by combining group differences, time trends and multiscale statistical analysis 
allowing the observer to quickly view and evaluate the material. It is our opinion that SiNoS  
analysis of time series is a very powerful statistical tool that may be used to complement 
conventional statistical methods. Figure 4 below will be used as an illustration of this. 
Figure 4.a illustrates curves representing a measurement of MAP every fourth second 
over a period of nine hours. The curves in both sham and aortoportal shunt groups are almost 
superimposed until shunt opening at 180 minutes (corresponding to measurement nr. 2800) 
where we observe an immediate and sustained fall in MAP in the shunt group. For the sake of 
illustration and comparison, a vertical line representing the time of aortoportal shunt opening 
is drawn through all figures. Figure 4.b illustrates the Plot of Smooths derived from the 
Gaussian Kernel smoothing with different bandwidths and the Mean SiNoS plot (figure 4.c) 
displays the corresponding significance map. Significant changes in the difference in MAP 
between the shunt and sham group are illustrated for the whole period of observation. The y-
axis in figure 4.c represents the window width of analysis and the x-axis the time points 
throughout the experiment. White areas depict time windows in which there is a statistically 
significant decrease in the MAP difference between the shunt and sham groups, and black 
areas time windows in which there is a statistically significant increase in the MAP difference. 
Dark grey areas represent time frames of no statistical significant change and light grey areas 
time frames with too few data points for statistical inference to be made at the respective scale 
of analysis.  
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At window width 800 (on the Y-axis of figure 4.c) in the time period of measurement 
nr.1000 to 1500, the MAP in the shunt group rises transiently above the MAP in the sham 
group (which is seen on closer inspection of figure 4.a, in the time period of approximately 58 
to 90 minutes). This pressure increase is flagged as significant as there is a white area in the 
Mean SiNos map corresponding to this time period (figure 4.c). Despite the statistical 
significance, the change probably only represents random pressure fluctuation. However, 
further on, in the time period measurement nr. 2500 to nr. 3200, the MAP difference changes 
again significantly in the opposite direction. By referring to figure 4.a we see that this 
corresponds to the fall in MAP in the shunt group when the shunt is opened. SiNoS analysis 
detects instantly the fall in MAP upon shunt opening. When the time frame is increased the 
change in difference is also significant over a longer time period. For example, taking the 
window width 2520 we see a significant change in MAP difference from shunt opening to 
measurement nr. 5000 – that is, if we take any time point from measurement nr. 2500 to nr. 
5000 and compare the MAP of the preceding 168 minutes with the following 168 minutes, 
there will be a significant change in MAP difference from the first time period to the next. It 
follows from this that the steeper the changes in MAP difference, the smaller time frame 
needed to detect it.  
Sampling MAP with 10-minute intervals yields a somewhat similar picture 
graphically (figure 4.d). In contrast to the approximately 8000 data points used in figure 
4.a, b and c, we are now dealing with 54 data points. As in the real time raw data, 
several noise spikes appear, though fewer, and a fall in MAP in the shunt group at time 

















Figure 4. Mean Arterial Pressure   
(MAP) in shunt vs. sham 
series. 
 a) MAP curves for the shunt 
(black) and sham (grey) 
groups based on real-time 
recordings over 9 hours. 
 b) Plot of Smooths.  
 c) Mean SiNoS plot for the 
difference in MAP between 
shunt and sham groups. 
d) MAP curves based on 




Analysis of this dataset with Repeated Measures ANOVA (figure 5) indicates 
significant within subject effects of time (p=0.000) and time*group interaction 
(p=0.008). However, it is not until 260 minutes after shunt opening (at time point 440 
minutes) that a significant difference in MAP trends in the two groups is detected 
(within subjects contrasts, p=0.042). This is followed by a period of significant and 
non-significant within subject contrasts until experiment termination with significance 
values varying from p=0.029 to p=0.044. Analyzing between-group effects reveals no 
group difference. In other words, contrary to SiNoS analysis, repeated measures 
ANOVA does not detect the fall in MAP upon shunt opening until 4 hours has passed 
and only at a few and sporadic time points does ANOVA find significant group 
differences  
 
Figure 5.   MAP curves based on sampling every 10 minutes. Ns; non-











Performing local ANOVAs with a Linear Mixed Model along the MAP dataset reveals 
significant group differences in the mean MAP in several time periods after shunt opening 
(marked with “G” for the respective time periods in figure 4.d). Only from 40 to 100 minutes 
do we find a significant group*time interaction (marked with “GT” in figure 4.d). This 
corresponds to the time period where SiNos also detected a group difference (marked by a 
white area in figure 4.c). Interestingly, Mixed Models ANOVA performed over a one-, and 
two hour time period immediately after shunt opening does not find a significant group*time 
interaction upon shunt opening, although the two curves split and stay so at this point (figures 
4.a and 4.d).  We observe, however, that Mixed Model ANOVA does find significant group 
differences over almost the entire period after shunt opening (figure 4.d). We do, of course, 
believe that the group difference occurring after shunt opening found by both SiNos, mixed 
models ANOVA, and partly repeated Measures ANOVA is biologically significant, as the 




















Six pig livers were resected with 62% (Low Portal Pressure Resection, LPR) and 75% (High 
Portal Pressure Resection, HPR) resulting in a portal venous pressure increase from a baseline 
of 6.1 mmHg to 8.2 and 12 mmHg respectively (figure 6). By sampling consecutive biopsies 
from the liver remnants we found differentially expressed genes in the HPR group to have 
functions related primarily to apoptosis, nitric oxide metabolism and oxidative stress, whereas 
differentially expressed genes in the LPR group potentially regulate the cell cycle (figure 7). 
Common to both groups was the upregulation of genes regulating inflammation, transport, 
cell proliferation and development and protein metabolism. Also common to both groups was 
both up- and downregulation of genes regulating cell-cell signaling, signal transduction, cell 
adhesion and translation. Genes regulating the metabolism of lipids, hormones, amines, and 
alcohol were downregulated in both groups (figure 8). The genetic regenerative response in 






Figure 6.    Portal venous pressure in the High Portal venous Pressure Resection (HPR) and      

















genes regulating cell cycle and apoptosis in both resection series. (Yellow 
markings - HPR – high pressure resection, 75 % PHx. Blue markings - LPR













igure 8. Functional classification of differentially expressed genes in the low pressure 
 
F
group (LPR) and high pressure group (HPR) in top-tables according to the 
functional classification methods of Gene Ontology and Online Mendelian 

















four-fold increase in flow to segments II, III and IV. The impact of this manipulation was 
studied in both an acute model (6 animals, 9 hours) using a global porcine cDNA microarra
chip and in a chronic model observing weight and histological changes (7 animals, 3 weeks). 
Gene expression profiling from the shunted segments does not suggest that increased 
sinusoidal flow per se results in activation of genes promoting mitosis. Hyperperfusion
three weeks results in the whole liver gaining a supranormal weight of 3.9 % of the total body
weight (versus the normal 2.5 %). Contrary to our hypothesis, the weight gain was observed 
on the non-shunted, portally perfused side, without an increase in sinusoidal flow (figure 9).  
 
Figure 9.   Liver / body weight ratio (%) by segments before and after 3 weeks of aortoportal    
 
he portally perfused and shunted sides revealed marked microscopic and macroscopic 
flow 
shunting of segments II, III and IV. The total liver weight increases over three weeks, 
the increase occurring in the non-shunted segments (I, V, VI, VII and VIII). 
T
differences after three weeks (figure 10). In this study, an isolated increase in sinusoidal 
did not have the same genetic, microscopic or macroscopic impact on the liver as that seen in 
the liver remnant after partial hepatectomy, indicating that increased sinusoidal flow may not 











Figure 10. Macro-and microscopic changes after three weeks of shunting: a) Close-up 
photograph of the transition zone between shunted and portally perfused in-vivo liver after 
three weeks. The shunted side exhibits smaller condensed lobuli and a brighter 
(hyperoxygenized) color, while the portally perfused side exhibits larger lobuli, b) HE stained 
section of the transition zone showing more condensed lobuli on the shunted side and larger 
lobuli with dilated portal venules and central veins on the portally perfused side, c) sections 
from areas perfused by the portal vein and by the shunt showing an even distribution of Ki67 







Apart from the surgical principles and practice of preoperative portal vein embolization to 
induce hyperplasia of the remnant to be after PHx, and portal vein decompression by 
portosystemic shunting to reduce sinusoidal congestion in the case of SFSS after liver 
transplantation, there is still no novel patient therapy available to aid and augment the process 
of liver regeneration be it after extended liver resections, after a toxic liver insult or in the 
cirrhotic patient (MARS substitutes the failing liver, but does not stimulate regeneration) - 
this in spite of all the modern technological advancements and the knowledge gained on the 
microscopic and molecular aspects of liver regeneration in the past 20-30 years. We suggest 
that it is time to turn back to the systemic large animal surgical research on liver regeneration 
as it offers a more integrated, systemic biological understanding of this complex process, and 
that a more clinically relevant progression could possibly be made with a closer collaboration 
































Large amounts of research has previously been done on the hepatic vascular bed and 
the regulation of liver flow [6-10,12,16,103-119] in particular by Wayne W. Lautt in 
Canada. Therefore, it was not our intention to describe well-known phenomena such 
the hepatic arterial buffer response (HABR) or analyze in detail the systemic changes 
incurred by liver resection and or aortoportal shunting. However, when studying the 
changes in mean arterial pressure, pulse, portal venous pressure and hepatic venous 
pressures, changes in flow in the liver arteries, portal vein and in the established shunt 
occurring during different grades of liver resection and arterial shunting of the left 
portal vein, we soon realized that using repeated measures ANOVA and Linear Mixed 
Models ANOVA was inadequate when sampling every fourth second for the nine hours 
that the acute experiments presented in paper 2 and 3 lasted. We speculated that the 
scale of resolution with which the hemodynamic changes were analyzed and the 
method with which true signals were selected from (instrumentation) noise would 
influence what we saw / found and, accordingly, which conclusions we could infer. We 
therefore searched for an alternative manner to analyze our repeated measures and 
eventually applied the Significant Nonstationarities (SiNoS) method. 
Paper 1 illustrated that the novel SiNoS analysis of our hemodynamic data is 
potentially a very useful adjunct to Repeated Measures ANOVA and Linear Mixed 
Models ANOVA. We advocate the use of this method of statistical analysis of repeated 
measures of real time data sampled in hemodynamic research because:  
 
1. The method’s plot of smooths gives good resolution of signal from 
noise, a great advantage when interpreting hemodynamic data from 
experimental surgery. 
2. The method allows for analysis of all data points from real time 
recordings that seems to increase the ability to detect significant features 
in the material.  
3. Analysis with multiple scales of resolution facilitates a more 
differentiated observation of the material, and 
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4. The graphical display afforded by this method, enables the researcher to 
appreciate the data in a more varied manner than is likely with more 
traditional graphics.  
The statistical method developed in paper does not employ the often-used 
Bonferroni correction but the method of False Discovery Rate (FDR) introduced by 
Benjamini and Hochberg [94]. When examining the data after statistical analysis one 
must therefore bear in mind the various biological and technical explanations for the 
trends detected. When this is done, many trends falsely labeled statistically significant 













































In this paper we aimed to investigate whether the grade of resection and hence the portal 
venous pressure and sinusoidal shear stress increase, would influence the regenerative 
response, as suggested by the “flow theory” described above. 
 The study showed that the regenerative response (as quantified by gene expression in 
the liver remnant) in the first six hours immediately after completion of the resection, is 
indeed influenced by the grade of resection and increase in portal pressure:- A “low pressure” 
resection (LPR) (62% liver resection) stimulated primarily the progression through the G1- 
phase of the cell cycle whereas a “ high pressure” (HPR) (75%) resection, primarily inhibited 
the apoptotic apparatus, regulated NO metabolism and oxidative stress. 
 Of all the 26 cell-cycle genes differentially expressed in this experiment, a major part 
(18 genes) was found in the HPR group (figure 7). Qualitatively, the genetic response after a 
high grade resection seems to center around the regulation of apoptosis, inhibiting death-
promoting pathways, particularly the caspase system, whereas, after a lower grade resection 
the differential regulation is primarily of genes regulating the cell cycle and cytoskeletal 
framework. Specifically, we observed in the LPR group, that genes promoting progression 
through the G1 phase were upregulated and genes inhibiting progression were downregulated. 
In addition, genes associated with the microtubuli apparatus and centrosomes were found 
upregulated. Over time, it seems that apoptosis is downregulated during the earlier time points 
(within 90 minutes) whereas cell cycle progression and microtubuli/centrosome regulation is 
regulated somewhat later (90 minutes to 4 hours post PHx). From these results it would seem 
that a higher grade of resection primarily results in an inhibition of the apoptotic apparatus 
whereas a lower grade resection stimulates primarily G1- phase cell cycle progression.  
 As the “flow theory” mentioned above potentially implies the activation of eNOS by 
increased sinusoidal shear stress after PHx, it was of interest to look for any differential 
expression of this gene (or iNOS and cNOS) in our experiments. We observed several genes 
regulating the activity of eNOS to be differentially expressed in the HPR group: - NOSIP 
competes with caveolin-1, recently found essential for liver regeneration [120],  in the binding 
of eNOS. Upon binding eNOS, NOSIP (upregulated in the HPR group) translocates the 
enzyme from the plasmalemma to the Golgi apparatus and possibly the mitochondria, 
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reflecting functional regulation by cellular compartmentalization after PHx. DDAH2 
(upregulated in the HPR group) regulates eNOS activity indirectly by its degradation of 
ADMA, which in turn converts eNOS to methylamine and citrulline. This could possibly 
reflect a very early physiological response in NO regulation and neovascularization in the 
liver remnant as angiogenesis is central to neovascularization of regenerated hepatocyte 
islands in the regenerating liver [121]. Genes encoding Calsium-calmodulin (essential for 
eNOS activity) were upregulated in both resection series and HSF-1 (activating eNOS via 
PKB/AKT) was upregulated in the HPR series, reflecting activation of eNOS in the liver 
remnants.   
Interestingly, several genes, previously found activated in response to various cellular 
stresses were found to be downregulated in our liver remnants (SOD1, catalase, and GSTP1). 
Taken together, this suggests that the cells in the liver remnants were under reduced oxidative 
stress over time. This is in contrast to Fausto’s metabolic theory of reactive oxygen species 
(ROS) triggering the regenerative response after PHx [122]. Dimmeler et al showed that 
laminar flow shear stress protects against oxidative stress by the upregulation of SOD [123] 
and Hojo et al [124] found that laminar fluid shear stress inhibited H2O2 induced JNK 
activation and increased GSH/GSSG ratio. Of the genes associated with redox cycling, all 
were differentially expressed in the HPR, whereas only one (catalase) was found in the LPR 
group. Taken together, this may suggest that the increased shear stress in the HPR group 
decreases the level of oxidative stress within the endothelial- and juxtaposed hepatocytes.   
 A microarray experiment cannot specifically falsify or confirm a null hypothesis, as it 
is, in essence, a screening technique. Yet, we applied the method in paper 2 to shed light on 
regeneration theories of portal pressure and sinusoidal shear stress and ventured to 
hypothesize that the immediate regenerative response in the liver remnant after a liver 
resection would vary according to the level of resection because of the differences in portal 
pressure incurred by varying levels of resection. We believe that the results in this paper 
indicate that there are qualitative and quantitative differences in the regenerative response 
depending on the level of resection and that these differences may be caused by differences in 
portal, and hence sinusoidal pressure and shear stress in the respective liver remnants. We 
concluded that further refined in vivo models of shear stress in the liver needed to be explored 
in order to investigate increased sinusoidal flow per se (without prior resection), in order to 








The hemodynamic changes in the liver remnant resulting from PHx results not only in 
increased flow and shear stress in the remaining sinusoids, but also increased delivery of 
hepatotrophic factors to the replicating hepatocytes. Therefore, to distinguish the effects of 
these two potentially different stimuli (increased sinusoidal flow/shear-stress vs. increased 
delivery of hepatotrophic factors), and further scrutinize the potential effects of increased 
sinusoidal flow, we hypothesized in paper 3 that, according to the “flow theory” of liver 
regeneration, it is the increased sinusoidal flow in itself, which is the primary stimulus to liver 
regeneration (and not the increased delivery per gram remaining liver of hepatotrophic factors 
in the portal blood). Consequently, selectively increasing the flow to segments II, III and IV 
(by creating an aortoportal shunt) should lead to similar gene expression profiles as those seen 
shortly after PHx, and over time, lead to hyperplasia / hypertrophy of these segments. 
 Gene expression profiling from the shunted segments does not suggest that increased 
sinusoidal flow per se results in activation of genes promoting mitosis. Hyperperfusion over 
three weeks results in the whole liver gaining a supranormal weight of 3.9 % of the total body 
weight (versus the normal 2.5 %). Contrary to our hypothesis, the weight gain was observed 
on the non-shunted side without an increase in sinusoidal flow. These results indicate that the 
isolated increase in sinusoidal flow does not have the impact on the liver as that seen in the 
liver remnant after partial hepatectomy, demonstrating that increased sinusoidal flow per se is 
not a sufficient stimulus for the initiation of liver regeneration.  
 How can we explain our observation that the non-shunted, portally perfused side of the 
liver grows after three weeks while the weight percentage of the shunted side does not change 
in the same period? Firstly, the shunted blood was arterial in origin. It may be that this 
increase in oxygenation of the liver parenchyma may have been unphysiological to such an 
extent that any potential growth stimulating flow stimulus on the endothelial surface was 
suppressed. However, a high oxygen tension in portal venous blood has been shown to be 
beneficial for regeneration after extended PHx in rats and for the outcome of acute liver 
failure in swine [125,126]. Furthermore, analysis of the flux of liver enzymes, GT, ALP and 
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bilirubin flux across the liver bed and cytokine analysis of blood draining the shunted 
segments in the acute series, and histological analysis of HE stained sections, does not suggest 
any immediate deleterious effect on the liver parenchyma as a result of the shunting. 
Secondly, ligating the left portal vein branch proximal to the anastomosed aortoportal shunt 
resulted in a portal pressure increased from 6.22 mmHg to 8.55 mmHg (P<0.05) however, the 
flow per gram liver in these portally perfused (not shunted) segments remained unchanged 
(1.57 to 1.53 mL/gram/minute, not significant) whereas the flow in the shunted segments 
increased significantly from an average of 0.61 to 2.89 mL/gram/minute after shunt opening 
giving a 4.75 fold increase in flow which is similar to the flow increase seen after a 75% PHx 
[101]. Thus, it may be that it is not the quantity of blood perfusing the liver sinusoids in the 
remnant which is detrimental to liver regeneration, but rather the quality of the blood (with 
hepatotrophic factors) as previously suggested by Michalapoulos [127]. Supportive of this 
theory is the findings of Ladurner et al. where extended hepatic resection with or without 
decompressive portocaval shunting (and thus significant differences in flow in the liver 
remnant) did not reveal differences in liver regeneration [128]. Conceivably equally 
important, are the increased metabolic tasks per gram remaining liver imposed on the liver 
remnant which may lead to its growth. 
 Finally, is it justifiable to study the process of liver regeneration without performing a 
resection? In our opinion, yes, because the moment one performs a liver resection, the relative 
increase in growth factors supplied, and the increase in metabolic demand on the liver 
remnant confounds the study of an isolated increase in flow per gram remaining liver 
parenchyma. It is therefore necessary to create an “unphysiological “state to study an isolated 









The purpose of paper 4 was to summarise previous experimental in-vivo research on liver 
regeneration in animals, beginning with the Eck fistula model in 1877 and up to present day 
investigations, focusing on how this field has developed as a result of the interplay between 
clinical challenges and preclinical surgical research. 
 The focus of research on liver regeneration after PHx during the last three decades has 
turned from examining extrinsic hepatic factors such as portal- and hepatic arterial blood flow 
and its content, to the intrinsic consequences these changes have in the extracellular matrix, 
the intracellular signal transduction mechanisms and genetic response in the liver. Newer 
studies in various cell culture models, rodent knockout- and knockdown models, stem cell 
transplantation, microarray analysis in rodent and porcine models, the impact of the immune 
system, blood platelets and serotonin, the complement system, cytokines, and the interaction 
between the many different cell types now known to regulate the regenerative process has 
unquestionably added much knowledge to the research on liver regeneration but at the same 
time, made the picture complex and seemingly increasingly intangible when it comes to the 
clinical application of the knowledge gained.  
 The surgical principles and practice of preoperative portal vein embolization to induce 
hyperplasia of the remnant to be after PHx, and portal vein decompression by portosystemic 
shunting to reduce sinusoidal congestion in the case of SFSS after liver transplantation are 
well established. Apart from these, there are no novel patient therapies available to aid and 
augment the process of liver regeneration after extended liver resections, toxic liver insults or 
in the cirrhotic patient. This is in spite of all the modern technological advancements and the 
knowledge gained on the microscopic and molecular aspects of liver regeneration in the past 
20-30 years. We suggest that it is time to turn back to the systemic large animal surgical 
research on liver regeneration as it offers a more integrated, systemic biological understanding 
of this complex process, and that a more clinically relevant progression could possibly be 
made with a closer collaboration between the hepatologist, liver surgeon/transplant surgeon 






1. SiNoS analysis of time series is a very powerful statistical tool that may be used to 
complement conventional statistical methods in the analysis of time series in 
circulatory research.  
2. The genetic regenerative response in the liver remnant to varies according to the level 
of resection and rise in portal pressure. 
3. An isolated increase in sinusoidal flow does not have the same genetic, microscopic or 
macroscopic impact on the liver as that seen in the liver remnant after partial 
hepatectomy, indicating that increased sinusoidal flow in itself is not be a sufficient 
stimulus in itself for the initiation of liver  
4. The vast amount of research to date performed on liver regeneration has had relatively 
little practical consequence for the patient with a failing liver with a few exceptions. 
Contemporary liver surgery therefore calls for a better understanding of the 
mechanisms controlling liver regeneration in order to design new treatment strategies 
























Models, topics and hypotheses for future research 
 
Many aspects of liver regeneration are unanswered. The work on the present thesis has 
resulted in some ideas for future experiments: 
 
1. Can increased energy reserves in the liver remnant aid regeneration?        
Rodent models of PHx from the 1970’s and canine models from the 1990’s have 
shown that the capacity of the liver remnant to regenerate after PHx is dependant 
upon an increased supply of energy [130-132]. After PHx in rats, Yoshioka et al 
showed that oxygen supply to the liver increases by increased hepatic artery flow. 
Simultaneously, the hepatic oxygen extraction rate increases, while the total 
energy load decreases along with increased DNA synthesis [133]. Arterialization 
of the liver remnant leads to improved survival in rats after extended hepatectomy 
[134-136], and this has also been shown to be beneficial in humans after extended 
hepatectomy [137]. In investigating the mechanisms behind SFSS, Smyrniotis et al 
studied the hemodynamic changes in different sized liver grafts in pigs finding that 
while the portal pressure and flow per gram liver increased inversely with graft 
size, the hepatic artery flow decreased. However, the hepatic arterial buffer 
response was preserved, even showing an increased response with decreasing graft 
size [138]. One could therefore hypothesize that a graded portal vein arterialization 
could prove beneficial for the function and regeneration of the marginal liver 
remnant and the small-for-size liver graft, as arterialization potentially leads to an 
optimal oxidative status and energy charge in the hepatocytes. Accordingly, a 
surgical model of extended hepatectomy with arterialization of the functionally 
small and deficient remnant with observations of energy charge and histological 
signs of regeneration could cast light on this aspect and potentially be used as a 
bridge to complete regeneration in patients with small-for-size grafts. 
 
2. The resected liver is itself a source of mitotic stimulus – can we utilize this 
fact?    In 1952, Glinos and Gey found the serum of partially hepatectomized rats 
to exert a growth-promoting action on fibroblasts in tissue culture [139]. Bucher 
and Wenneker reported an increased number of mitoses in the non-hepatectomized 
partner in parabiotic rats with cross circulation indicating the presence of growth 
stimulating factors in the effluent from the liver remnant [140,141]. This 
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hypothesis was corroborated in in-vivo rodent models by several investigators who 
observed increased liver cell mitosis in intact animals injected with serum from 
hepatectomized counterparts [142,143]. To circumvent the changes in portal 
hemodynamics caused by PHx, Siegel conducted canine experiments in the 
early1960’s with autotransplanting small liver grafts to the jejunal mesentery, later 
randomizing the animals to a 70 % PHx of the native liver. In contrast to control 
groups, the autografts in the animals with 70 % PHx did not undergo atrophy, 
indicating again a growth stimulus from the resected liver to the autografts via the 
systemic circulation [144]. Similarly, another experiment showed that autografts 
transplanted to the neck, did not undergo atrophy, tentatively stimulated by the 
native liver manipulated with an Eck fistula (in contrast to animals without an Eck 
fistula) [145]. Thomford showed similar results in 1965 in dogs with heterotop 
allografts, where the grafts did not suffer from atrophy when the native liver, 
receiving all the portal blood, was resected; again indicating a growth stimulating 
effect from the liver effluent after PHx [146]. 14 years later Starzl extracted 
cytosol from hepatectomized canine livers (48 and 72 hours after PHx) injecting it 
into the portal vein stump of Eck fistula dogs observing a proliferative response 
[147]. Further investigations of possible growth stimulatory substances in the liver 
effluent from partially hepatectomized pigs were performed by van Hoorn-
Hickman in 1981 by cross circulation with recipient animals or exchange 
perfusion. Increased thymidine kinase activity and mitotic indices in biopsies from 
portocaval shunted (recipient) pigs corroborated Starzl’s previous observations in 
dogs [148]. Kahn also showed in 1982 that a stimulatory substance was transferred 
from a transplanted partially hepatectomized liver to the host liver (which had a 
portocaval shunt), stimulating a proliferative response in the latter (as judged by 
increased thymidine kinase activity and mitotic indices). The authors speculated 
whether this phenomenon could be clinically useful in aiding liver regeneration in 
the host liver in patients with liver failure treated by auxiliary liver grafting [149]. 
This theory leads to the speculation of whether the development of an acute or 
acute-upon-chronic liver failure large animal model could be used to test the 
benefit of injecting serum extracts of liver hepatotrophic substances from resected 
livers in aiding the regeneration of the damaged liver? Is it possible that the 
remnant liver after an extensive liver resection could be aided in regeneration by 
infusion of a concentrate of the patient’s own serum in the portal vein and could a 
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small-for-size graft procured from living donor split-liver-grafting profit or in 
some way be supported by the stimulus that the serum of the donor could offer? 
3. What stops the regeneration process? What is the hepatostat? And how ca we 
utilize it to aid the liver with insufficient regeneration?                                    
An area that has received relatively little attention to date has been the research on 
the metabolic control of liver size and the mechanisms controlling the termination 
of regeneration. As the liver to body weight ratio is relatively well conserved 
across species (i.e. 2.5 %) there seems to be a “hepatostat” regulating liver size.  Is 
there a systemic metabolic or hormonal feedback mechanism involved, or is it 
primarily intracellular? We suggest a model of liver transplantation of a large graft 
into a small recipient with a longitudinal metabolic, hormonal and genetic study 
parallel with volumetric measurements of the liver undergoing functional atrophy. 
The aim being to detect substances both within the liver itself acting in some 
paracrine manner and substances in the systemic circulation possibly acting 
through a negative-feedback axis. 
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